No data to
display.
Tracon Pharmaceuticals, Inc. revenue decreases to $9 million in quarter ended Jun 30, 2023 from previous quarter
By NewsInMinutes on Aug 24, 2023 | 03:34 AM IST
| Current Reporting | Revenue | Net Income | Profit/Loss |
|---|---|---|---|
| Jun 2023 | $9 million | $6.29 million | loss |
| Sep 2022 | $0 | $6,435 | loss |
Tracon Pharmaceuticals, Inc. [TCON] has reported $6.29 million loss for the fiscal quarter ending Jun 30, 2023.
Revenue for the quarter was $9 million with operating income of $779,000 .
The Sandiego, California (CA)-based company operating in the biological products, except diagnostic substances sector has total shareholders equity of $15.74 million.
Also read:
This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.